S Giancane

Plain English
This study looked at two types of kidney transplant surgeries: robotic-assisted (RAKT) and open (OKT), specifically using kidneys from deceased donors. It found that robotic transplants had similar success rates to open transplants, with both methods showing comparable patient outcomes after surgery and during the follow-up period, even though more patients with open transplants experienced complications like delayed kidney function. This is important because it shows that robotic surgery can be a viable option for kidney transplants, potentially making the process easier and less invasive for patients. Who this helps: Patients needing kidney transplants from deceased donors.

Plain English
This study examined the surgery outcomes for patients with advanced kidney cancer, specifically those with tumors that may extend into major blood vessels. Out of 32 patients treated between 2017 and 2020, successful surgery was achieved for various tumor stages, with low complication rates—only 3 experienced minor complications, and none had major issues post-surgery. Importantly, specialized surgical techniques led to successful treatment for patients with the most severe cases involving blood vessel blockage. Who this helps: This research benefits patients with advanced renal cell carcinoma, as well as the doctors who treat them.

Plain English
This study looked at the semen quality of men who had recovered from COVID-19. It found that 25% of the men exhibited abnormal semen conditions, specifically oligo-crypto-azoospermia, which means they had low sperm counts or no sperm. Additionally, 76.7% of participants had high levels of a protein (IL-8) linked to inflammation in their semen, indicating potential damage. The findings suggest that men recovering from COVID-19 should have their semen quality assessed to understand any reproductive health impacts. Who this helps: This helps men who have recovered from COVID-19, particularly those concerned about fertility.

Plain English
This study reviewed a technique developed at the University of Florence for robot-assisted kidney transplants from both living and deceased donors over three years. Out of 160 kidney transplants performed, 39 (or 24%) were done using this robotic method, with a notable increase in its use each year: from 11 in 2017 to 15 in 2019. The findings showed that while specific complications were slightly more common in deceased donor transplants, overall, the robotic method is safe and effective for both types of kidney donors. Who this helps: This benefits patients needing kidney transplants, particularly those receiving organs from deceased donors.

Plain English
This study looked at a robotic surgery method used for kidney donation at the University of Florence, where 36 patients had their kidneys removed with robotic assistance. They found that the surgery was performed safely, with no major complications during or after the procedure, and the average surgery time was about 230 minutes. This method is significant because it shows that using robots can make kidney donation surgeries safer and more efficient for donors. Who this helps: This benefits kidney donors and the surgeons performing the procedures.

Plain English
This study looked at the use of robots to assist in kidney transplants from deceased donors, starting a new program at an academic hospital. Researchers performed 11 robot-assisted transplants from deceased donors and found that all surgeries went smoothly, with an average operation time of about 3 hours and a short hospital stay of about 8 days. Most patients showed improved kidney function after the surgery, although 30% had complications, mostly minor. Who this helps: This benefits patients needing kidney transplants, particularly those with access to robotic surgical facilities.

Plain English
This study explored how a special imaging technique called indocyanine green fluorescence videography (IFV) can help doctors measure blood flow to kidney grafts and ureters during robotic kidney transplants. Out of six patients who received this treatment, there were no major complications, and the average kidney function after one year showed a promising estimated filtration rate of 64.2 mL/min, indicating good graft health. This research is important because it shows that using IFV during surgery is safe and effective, potentially helping to improve outcomes in kidney transplant patients. Who this helps: Patients undergoing robotic kidney transplants.

Plain English
This study looked at a new method for kidney removal and transplantation using robots, performed at a hospital over a year. They successfully completed 5 surgeries without any major problems, with patients losing a median of 182 mL of blood and having a smooth recovery—no blood transfusions or complications were reported. This method is important because it shows that robot-assisted surgeries can be safe and effective, improving outcomes for both kidney donors and recipients. Who this helps: Patients needing kidney transplants and their living donors.

Plain English
This study reports the first successful case of using robotic surgery to transplant a kidney from a deceased donor into a 37-year-old patient with a genetic kidney disease called autosomal dominant polycystic kidney disease (ADPKD). The procedure was completed safely, demonstrating that robotic kidney transplantations can work well even for complex cases like this, expanding options for patients with similar conditions. This is important because it shows that advanced surgical techniques can improve outcomes for difficult transplant cases. Who this helps: Patients with autosomal dominant polycystic kidney disease needing a kidney transplant.

Plain English
This study looked at complications after partial nephrectomy, a surgery for kidney tumors, in nearly 1,000 patients across 19 centers. They found that about 13.1% of patients had surgical complications, with some being more severe, while 5.6% had medical complications. Factors like a patient's overall health score (ECOG) and the type of surgical method used significantly influenced the likelihood of these complications, meaning that doctors should carefully assess these factors before surgery to improve patient outcomes. Who this helps: Patients undergoing kidney surgery.

Plain English
This study looked at how different treatments for erectile dysfunction (ED) affect men after prostate surgery, comparing those who received no treatment to those who used oral medications. Among 196 patients, those who used medication had a better chance of recovering erectile function, with 68.7% of men who had bilateral surgery recovering compared to 61% with no treatment, and 44% for unilateral surgery compared to 29% with no treatment. This research highlights the importance of early medication use for better recovery after prostate surgery. Who this helps: This helps men recovering from prostate surgery who are dealing with erectile dysfunction.

Plain English
This study looked at two surgical techniques for removing kidney tumors: simple enucleation (SE) and standard partial nephrectomy (SPN). Researchers compared the outcomes of 198 patients who had each procedure and found that SE resulted in less blood loss (177 cc vs. 221 cc) and shorter surgery times (121 minutes vs. 147 minutes) while having a significantly lower risk of having a positive surgical margin (1.4% for SE vs. 6.9% for SPN). This matters because SE may be a safer option for patients needing kidney surgery, leading to better outcomes and less risk of cancer remaining after the operation. Who this helps: Patients with kidney tumors.

Plain English
This study looked at two types of surgery for early-stage kidney cancer: simple tumor enucleation (TE) and radical nephrectomy (RN). Researchers analyzed data from 475 patients and found that both surgeries had similar long-term outcomes in terms of cancer recurrence and survival rates, with 5-year cancer-specific survival rates of 94.4% for TE and 92.1% for RN, showing that both options are effective. The results suggest that TE can be a safe alternative to RN for certain patients with early-stage kidney cancer, as long as the tumors can be completely removed. Who this helps: This helps patients with early-stage kidney cancer by offering a less invasive treatment option.

Plain English
This study looked at how testosterone levels in the blood affect urinary control and sexual function in men with localized prostate cancer who were about to have surgery. Researchers found that the average testosterone level before surgery was 13.5 nmol/l, and 23.7% of the patients had low testosterone. Men with normal testosterone experienced better sexual function scores—74.8 compared to 64.8 in those with low testosterone—suggesting that higher testosterone is linked to better outcomes after surgery. Who this helps: This research benefits patients with prostate cancer, particularly those facing surgery, by highlighting the importance of checking testosterone levels before treatment.

Plain English
Researchers used advanced imaging techniques to study healthy bladder tissue and cancerous tissue from biopsies. They found that cancer cells had different shapes and sizes compared to normal cells, along with distinct differences in how they emitted light. This new imaging method could improve how doctors diagnose bladder cancer during examinations. Who this helps: Patients with bladder cancer.

Plain English
Researchers tested whether ultrasound could accurately measure how much of the colon was damaged and how severe the inflammation was in 57 patients with ulcerative colitis (a serious bowel disease). The ultrasound was highly accurate—correctly identifying the extent and severity of disease 91-93% of the time when compared to other imaging methods and surgical findings. After patients received intensive treatment for 10 days, ultrasound showed significant improvement in their inflammation, proving the technology could track whether medications were actually working. This matters because ultrasound is fast, safe, and non-invasive, giving doctors a practical tool to measure disease severity, decide on treatment, and objectively confirm that treatment is helping—without exposing patients to radiation or surgery.

Plain English
This study looked at the effects of a surgical procedure called distal splenorenal shunt (DSRS) on hormone levels and blood sugar control in patients with liver cirrhosis. Researchers found that after the surgery, patients had higher levels of glucagon (increased from about 181 to 255 pg/ml) and ammonia, while the effectiveness of glucagon decreased over the year. This is important because it shows the surgical procedure changes certain hormone levels without harming liver function, which could impact how these patients manage their blood sugar. Who this helps: This helps patients with cirrhosis who may undergo this surgical procedure.

Plain English
Researchers compared how 13 liver disease patients (without fluid buildup) and 13 healthy people handled sodium when lying in bed for 24 hours on a controlled low-salt diet. The liver disease patients excreted roughly twice as much sodium in their urine despite having less sodium filtered through their kidneys, and this extra sodium loss was driven by higher levels of a hormone called ANP (atrial natriuretic peptide) rather than the typical sodium-conserving hormones. Why it matters: This finding suggests that liver disease patients have a built-in mechanism—through ANP—that forces them to shed excess sodium, which may actually help prevent them from developing dangerous fluid accumulation (ascites) that typically accompanies advanced liver disease.

Plain English
This study looked at how effective CDP-choline, a supplement, is for improving symptoms of mild to moderate brain aging in 237 patients. The findings showed significant improvements in cognitive and behavioral functions from the treatment, with a noticeable enhancement in areas like social life and attention after just three weeks. This improvement was not only immediate but also lasted for a short time after treatment ended, showing the potential lasting benefits of CDP-choline. Who this helps: This helps patients experiencing brain aging and their families by providing a promising treatment option.